Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 235,239 | -535,977 | -703,488 | -418,780 | -554,128 |
| Depreciation Amortization | -2,553 | -1,779 | 31,213 | 37,915 | 26,911 |
| Accounts receivable | -201,661 | -185,699 | -61,638 | -51,650 | -10,461 |
| Other Working Capital | -716,606 | -481,089 | -39,470 | -98,166 | 554,056 |
| Other Operating Activity | 479,794 | 703,551 | 448,037 | 87,509 | 91,088 |
| Operating Cash Flow | $-205,787 | $-500,993 | $-325,346 | $-443,172 | $107,466 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 436,012 | -144,088 |
| PPE Investments | -136,956 | -76,106 | -30,824 | -38,490 | -82,202 |
| Purchase Of Investment | -1,099,595 | -2,048,940 | -1,937,856 | -1,800 | N/A |
| Sale Of Investment | 2,002,112 | 1,868,482 | 923,224 | N/A | N/A |
| Purchase Sale Intangibles | -10,000 | 90,761 | -1,427 | 99,691 | 108,069 |
| Other Investing Activity | -10,000 | 90,761 | -1,427 | 99,691 | 104,569 |
| Investing Cash Flow | $755,561 | $-165,803 | $-1,046,883 | $495,413 | $-121,721 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,127,400 | N/A | 291,150 |
| Debt Repayment | -68 | N/A | -823,232 | N/A | N/A |
| Common Stock Issued | 79,525 | 51,246 | 30,043 | 569,334 | 396,010 |
| Other Financing Activity | 45,349 | 73,758 | -101,704 | -7,765 | -4,837 |
| Financing Cash Flow | $124,806 | $125,004 | $232,507 | $561,569 | $682,323 |
| Beginning Cash Position | 444,009 | 985,801 | 2,125,523 | 1,511,713 | 843,645 |
| End Cash Position | 1,118,589 | 444,009 | 985,801 | 2,125,523 | 1,511,713 |
| Net Cash Flow | $674,580 | $-541,792 | $-1,139,722 | $613,810 | $668,068 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205,787 | -500,993 | -325,346 | -443,172 | 107,466 |
| Capital Expenditure | -136,956 | -76,106 | -30,824 | -38,490 | -82,202 |
| Free Cash Flow | -342,743 | -577,099 | -356,170 | -481,662 | 25,264 |